With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths worldwide.

Surgeon-performed transoral and transcervical ultrasound detected oropharyngeal tumours with 86% accuracy, outperforming MRI, a trial shows.

Feb. 19, 2003 — High-frequency B-scan ultrasound is useful for assessing the extent of squamous conjunctival neoplasia (SCN) and can change the operative plan in some cases, according to the ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

People with locally advanced head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The U.S. Food and Drug Administration ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...